CTOs on the Move


 
Rgenix is a preclinical stage pharmaceutical company with a mission to develop the world`s first cancer therapies designed specifically to target cancer metastasis, the main cause of mortality in cancer patients. Rgenix is leading the revolution in next-generation cancer therapies with first-in-class lead drug candidates for several aggressive cancer subtypes, including Triple-Negative Breast Cancer, Melanoma and Colorectal Cancer.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.rgenix.com
  • 310 East 67th Street Suite 1-12
    ‎New York, NY USA 10065
  • Phone: 646.856.9261

Executives

Name Title Contact Details

Funding

Rgenix raised $33M on 06/15/2016

Similar Companies

Vir Biotechnology

Vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world`s most challenging infectious diseases for which solutions are non-existent or inadequate. Vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. The company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.

Alios BioPharma

Alios BioPharma is a South San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

www.velosbio.com

VelosBio, Inc. operates as a biotechnology firm specializing in oncology.

Reichert Analytical Instruments

Reichert Analytical Instruments is a Depew, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Novagen

Novagen is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.